Plain-English translation of NCT07436429 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
When you have a sudden, severe heart attack (called ST-elevation myocardial infarction or STEMI), doctors need to act fast to restore blood flow to your heart. This registry is studying whether using a drug-coated balloon—a newer technique—might be a safer and simpler alternative to the standard metal stent that's typically placed during emergency heart treatment.
The standard treatment with metal stents works well, but this registry exists because doctors want to know if the newer drug-coated balloon approach might avoid some of the complications that can happen with stents, such as blood clots forming later or the vessel narrowing again.
You likely qualify if…
You likely don't qualify if…
You will receive the drug-coated balloon procedure as your emergency heart attack treatment—this happens during your hospital admission. After that, the research team will track your health outcomes and any complications over time as part of this registry study. You will not need to take a new medication; instead, the focus is on monitoring how well this balloon technique works for treating your heart attack.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Austria
Enrollment target
~300 participants
Started
February 2026
Primary completion
July 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Riccardo Terzi, MD, BSc
Universitatsklinikum AKH wien
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.